GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Loans Receivable

K Pharma (TSE:4896) Loans Receivable : 円0 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Loans Receivable?

K Pharma's Loans Receivable for the quarter that ended in Mar. 2024 was 円0 Mil.


K Pharma Loans Receivable Historical Data

The historical data trend for K Pharma's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Loans Receivable Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Loans Receivable
- - -

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial - - - - -

K Pharma Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


K Pharma Loans Receivable Related Terms

Thank you for viewing the detailed overview of K Pharma's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


K Pharma (TSE:4896) Business Description

Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines